Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

000766 Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.

Trading 10-28 14:03:09

14.80

+0.23

+1.58%

High15.10	Low14.62	Vol8.59M
Open14.95	D1 Closing14.57	Amplitude3.29%
Mkt Cap14.30B	Tradable Cap14.30B	Total Shares966.00M
T/O128.00M	T/O Rate0.89%	Tradable Shares966.00M
P/B6.09	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"000766","market":"SZ","secType":"STK","nameCN":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.","latestPrice":14.8,"timestamp":1793167389000,"preClose":14.57,"halted":0,"volume":8586628,"delay":0,"changeRate":0.0158,"floatShares":966000000,"shares":966000000,"eps":0.0117,"marketStatus":"Trading","change":0.23,"latestTime":"10-28 14:03:09","open":14.95,"high":15.1,"low":14.62,"amount":128000000,"amplitude":0.0329,"askPrice":14.8,"askSize":1,"bidPrice":14.79,"bidSize":275,"shortable":0,"etf":0,"ttmEps":0.0117,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1793170800000},"marketStatusCode":2,"adr":0,"adjPreClose":14.57,"symbolType":"stock","openAndCloseTimeList":[[1793151000000,1793158200000],[1793163600000,1793170800000]],"highLimit":16.03,"lowLimit":13.11,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":966494707,"isCdr":false,"pbRate":6.09,"roa":"--","peRate":1264.957265,"roe":"0.09%","epsLYR":0.04,"committee":0.761785,"marketValue":14304000000,"turnoverRate":0.0089,"status":0,"floatMarketCap":14291000000},"requestUrl":"/m/hq/s/000766","defaultTab":"news","newsList":[{"id":"1195141619","title":"Tonghua Golden-Horse Pharmaceutical Reports 92.1% Drop in Net Profit for First Three Quarters","url":"https://stock-news.laohu8.com/highlight/detail?id=1195141619","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195141619?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:28","pubTimestamp":1793003295,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) has released its third-quarter report for 2026.For the first three quarters, the company achieved operating revenue of 737 million...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0077","BK0239","000766"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104899699","title":"Tonghua Golden-Horse Reports 57.72% Drop in First-Half Net Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1104899699","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104899699?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:32","pubTimestamp":1787214768,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) has released its interim results for the first half of 2026, revealing a significant decline in profitability amid challenging...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0239","000766","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657961401","title":"Tonghua Golden-Horse Signs Non-Binding Acquisition Agreement to Purchase Drug Research Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2657961401","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657961401?lang=en_us&edition=fundamental","pubTime":"2026-08-07 18:08","pubTimestamp":1786097303,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry  signed a non-binding agreement to purchase a controlling stake in Bajiayi Pharmaceutical, according to a Friday filing with the Shenzhen bourse.Bajiayi is a pharmaceutical research company with 23 drug research and development patents.The agreement has a 90-day exclusivity agreement, which would not allow Bajiayi to entertain acquisition negotiations with other parties.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["000766","BK0239","BK0060","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103242279","title":"Tonghua Golden-Horse Plans to Acquire Majority Stake in Eight Plus One Pharma to Strengthen Neurological Disease Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=1103242279","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103242279?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:08","pubTimestamp":1786014514,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (000766.SZ) has announced that its wholly-owned subsidiary, Guilin Golden-Horse Innovation Investment Co., Ltd. (referred to as \"Guilin...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000766","BK0077","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648098511","title":"Golden-Horse Pharmaceutical Chair Pledges to Buy Up to 20 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648098511","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648098511?lang=en_us&edition=fundamental","pubTime":"2026-07-01 18:03","pubTimestamp":1782900231,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry  said Chair and General Manager Zhang Yufu plans to increase his stake by 10 million yuan to 20 million yuan within six months, following the drug registration of ambuciamide succinate tablets on June 25.Zhang, who currently holds 0.05% of the company, previously completed a similar buyback in March, according to a Wednesday filing with the Shenzhen bourse.Shares of the drug company closed 2% lower Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0060","BK0239","000766","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648511561","title":"Tonghua Golden-Horse Pharmaceutical Industry's Stock Fluctuates More Than 20% for Two Straight Trading Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2648511561","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648511561?lang=en_us&edition=fundamental","pubTime":"2026-07-01 17:46","pubTimestamp":1782899176,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry's  stock fluctuated more than 20% for two straight trading sessions on June 29 and 30, according to a Wednesday filing with the Shenzhen bourse.The stock movement coincided with the approval of its anveracrine succinate tablets for mild to moderata Alzheimer's, the filing said.Shares closed 2% lower on Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","BK0060","000766","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134283892","title":"Key Market Announcements and Trading Alerts for July 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1134283892","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134283892?lang=en_us&edition=fundamental","pubTime":"2026-07-01 07:47","pubTimestamp":1782863252,"startTime":"0","endTime":"0","summary":"This article provides a summary of significant corporate announcements and trading actions for July 1, 2026. Trading Halts and Resumptions Several companies have announced trading suspensions. ST...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0070","002625","600233","BK0220","000766","BK0177","BK0014","BK0072","000420","000656","000767","BK0188","688571","BK0194","BK0108","BK0201","LU1997244956.HKD","BK0183","000021","IE00BYQNZ168.SGD","BK0003","BK0006","BK0100","BK0041","LU1997245177.USD","BK0005","300861","BK0235","BK0058","000601","001373","BK0182","BK0195","BK0065","LU2289578879.USD","000595","BK0174","600892","BK0226","BK0044","BK0094","BK0214","BK0075","BK0089","BK0167","LU2211815571.USD","BK0090","BK0071","BK0277","002635","301248","BK0153","BK0257","BK0033","BK0165","BK0208","600728","BK0133","BK0229","002653","BK0138","BK0132","BK0103","BK0139","BK0198","300302","BK0261","BK0018","BK0233","688260","BK0086","LU1997245094.SGD","BK0152","BK0197","BK0240","BK0196","LU0593848301.USD","BK0076","IE00B12V2V27.USD","BK0030","BK0232","BK0012","BK0271","BK0000","002106","BK0002","BK0028","000017","BK0175","BK0077","BK0224","BK0147","BK0102","002628","BK0098","BK0217","300368","688408","BK0060","002313","601766","BK0251","BK0111","002943","BK0259","688012","BK0279","BK0231","603580","BK0273","600872","BK0155","BK0239","BK0185","IE00BYTNYN87.SGD","603559","BK0260","603789","300573","603389","002458","300179","688319","002326","603137","605020","BK0010","LU2495084118.USD","BK0148","01766","BK0095","BK0123","002738","BK0057"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149943923","title":"Tonghua Golden-Horse Chairman and General Manager Plans Share Purchase Worth 10 to 20 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1149943923","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149943923?lang=en_us&edition=fundamental","pubTime":"2026-06-30 22:01","pubTimestamp":1782828079,"startTime":"0","endTime":"0","summary":"On the evening of June 30th, Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SZSE: 000766) released an announcement disclosing a planned share purchase by its leadership. The company stated...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000766","BK0077","BK0239","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646933422","title":"Golden-Horse Pharma Secures Registration Certificate for Anveracrine Succinate Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2646933422","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646933422?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:24","pubTimestamp":1782458652,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical (SHE:000766) obtained a drug registration certificate for anveracrine succinate tablets, according to a Shenzhen bourse filing on Friday.The drug is used for the treatment of symptoms of mild-to-moderate Alzheimer's disease.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","000766","BK0077","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156401798","title":"Golden-Horse Pharmaceutical Receives Regulatory Approval for New Alzheimer's Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1156401798","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156401798?lang=en_us&edition=fundamental","pubTime":"2026-06-25 15:48","pubTimestamp":1782373719,"startTime":"0","endTime":"0","summary":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SHE: 000766) has announced that it has received the Drug Registration Certificate from the National Medical Products Administration for its...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0077","BK0060","000766"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793167395691,"stockEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":-0.0408},{"period":"3month","weight":-0.1094},{"period":"6month","weight":-0.4094},{"period":"1year","weight":-0.425},{"period":"ytd","weight":-0.47}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.0471},{"period":"6month","weight":-0.1128},{"period":"1year","weight":-0.0872},{"period":"ytd","weight":-0.0808}],"compareStock":{"symbol":"000001.SH","name":"SSE Comp"},"companyName":"通化金马药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41731人(较上一季度减少6.72%)","perCapita":"23138股","listingDate":"1997-04-30","address":"吉林省通化市二道江区金马路999号","registeredCapital":"96649万元","survey":"　　通化金马药业集团股份有限公司的主营业务是医药产品的研发、生产与销售。公司的主要产品是琥珀酸安维吖啶片、复方嗜酸乳杆菌片、风湿祛痛胶囊、清肝健脾颗粒、芩石利咽口服液、乳酸亚铁口服液。公司获得了高新技术企业，荣获“中华民族医药百强品牌企业”、2015年度最具资本力企业奖、2017创新中国十大发展潜力企业、“2022-2023年度中国医药制造业百强”、2023年度中国化药企业TOP100等称号。","listedPrice":7.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.,000766,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票老虎,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票老虎国际,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.行情,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票行情,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股价,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股市,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票价格,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票交易,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票购买,Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.(000766) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction